Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × cabazitaxel × 1 year × Clear all

Phase

Status

Recruiting 9 Active not recruiting 8 Completed 7 Terminated 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 100 Nivolumab 40 Carboplatin 40 Cyclophosphamide 39 venetoclax 29 Gemcitabine 29 Paclitaxel 27 atezolizumab 26 fludarabine 25 Cisplatin 25 Azacitidine 24 Docetaxel 22 Dexamethasone 22 Specimen Handling 21 Magnetic Resonance Spectroscopy 21 Bevacizumab 21 Biopsy 20 Radiotherapy 19 Pemetrexed 19 Rituximab 17 Fluorouracil 16 durvalumab 15 Leucovorin 15 Radiosurgery 14 Cytarabine 14 spartalizumab 13 Cetuximab 12 Capecitabine 12 tislelizumab 11 olaparib 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03764540 2025-04-13

CABPOSTAAT

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Terminated

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡